Instrument Business Outlook (IBO) and Strategic Directions International (SDi) join together to take a look at what the analytical and life science instrument market can expect in this challenging year, as well as what the long-term outlook for the industry is. Given the unprecedented nature of the current pandemic, we are augmenting our annual IBO 2020 mid-year forecast.

Top industry analysts will look at the impact of COVID-19 on the financial performance of leading instrument companies, and on the markets for important laboratory technologies themselves. They will present key findings from projections contained in the freshly updated 2020 SDi Global Assessment Report and discuss new data tools for the second half of the year to track the progress of recovery in the pharma/biotech/CRO and academic sectors.